Roberta Magliozzi
Verona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications
Cortical lesions in multiple sclerosis: 25 years of progress, remaining challenges and future directions.
Journal: Nature reviews. Neurology
Published: August 20, 2026
Choroid plexus morphological and microstructural changes across inflammatory phenotypes in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 21, 2026
Genetic subtypes of multiple sclerosis severity are uncoupled from inflammatory lesion burden.
Journal: Acta neuropathologica
Published: June 16, 2026
Rethinking prognosis in multiple sclerosis: a multiaxial perspective.
Journal: Nature reviews. Neurology
Published: April 13, 2026
Quantitative MRI Uncovers Subtle Cortical Damage in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Journal: Annals of clinical and translational neurology
Published: March 08, 2026
Paramagnetic Rim Lesions and Choroid Plexus Volume at Diagnosis Are Associated With Cognitive Progression Independent of Relapse and MRI Activity in Early Relapsing-Remitting Multiple Sclerosis.
Journal: Annals of clinical and translational neurology
Published: March 05, 2026
Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomes.
Journal: Therapeutic advances in neurological disorders
Published: December 09, 2025
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: May 01, 2025
A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 04, 2025
Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelination.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 25, 2025
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation.
Journal: Cell
Published: January 30, 2025
Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications.
Journal: The Lancet. Neurology
Published: November 14, 2024
Last Updated: 09/26/2026